Maculopathy as a Complication of Blood-Brain Barrier Disruption in Patients with Central Nervous System Lymphoma

American Journal of Ophthalmology

Volumn 144, Issue 1, 2007, Pages

  Galor, Anat ^a   Ference, Sandra J ^a   Singh, Arun D ^a   Lee, Michael S ^b   Stevens, Glen H J ^a   Perez, Victor L ^a   Peereboom, David M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOFOS; MANNITOL; METHOTREXATE;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD BRAIN BARRIER DISRUPTION; CASE STUDY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HYPERPIGMENTATION; LYMPHOMA; MALE; MEDICAL RECORD REVIEW; METHODOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULOPATHY; RETROSPECTIVE STUDY; TIGHT JUNCTION; VISUAL ACUITY;

EID: 34250764922     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.03.057     Document Type: Article

References (8)

1. Neuwelt E.A., Goldman D.L., Dahlborg S.A., et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 9 (1991) 1580-1590
2. McAllister L.D., Doolittle N.D., Guastadisegni P.E., et al. Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46 (2000) 51-60 discussion 60-61
3. Margo C.E., and Murtagh F.R. Ocular and orbital toxicity after intracarotid cisplatin therapy. Am J Ophthalmol 116 (1993) 508-509
4. Watanabe W., Kuwabara R., Nakahara T., et al. Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas. Graefes Arch Clin Exp Ophthalmol 240 (2002) 1033-1035
5. Miller D.F., Bay J.W., Lederman R.J., Purvis J.D., Rogers L.R., and Tomsak R.L. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas. Ophthalmology 92 (1985) 402-406
6. Lauer A.K., Wobig J.L., Shults W.T., Neuwelt E.A., and Wilson M.W. Severe ocular and 142 orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy. Am J Ophthalmol 127 (1999) 230-233
7. Millay R.H., Klein M.L., Shults W.T., Dahlborg S.A., and Neuwelt E.A. Maculopathy associated with combination chemotherapy and osmotic opening of the blood-brain barrier. Am J Ophthalmol 102 (1986) 626-632
8. Smith J.R., Rosenbaum J.T., Wilson D.J., et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109 (2002) 1709-1716